| Daniel Whalen, | |
|
1601 Coalton Rd, Superior, CO 80027-4610 | |
| (303) 391-4702 | |
| Not Available |
| Full Name | Daniel Whalen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1601 Coalton Rd, Superior, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770032591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 21496 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Whalen, 1601 Coalton Rd, Superior, CO 80027-4610 Ph: () - | Daniel Whalen, 1601 Coalton Rd, Superior, CO 80027-4610 Ph: (303) 391-4702 |
News Archive
GTC Biotherapeutics, Inc.'s ("GTC", NASDAQ: GTCB) received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market (the "Staff Determination") on September 17, 2009, indicating that unless GTC requests a hearing before the NASDAQ Listing Qualifications Panel (the "Panel"), the Company's securities would be subject to delisting from The NASDAQ Capital Market due to non-compliance with the $35 million market value of listed securities requirement as set forth in Listing Rule 5550(b)(2).
The Centers for Medicare & Medicaid Services published a rule Monday detailing how states should coordinate certain elements of health exchanges and Medicaid.
By combining a conventional laboratory measurement of blood clotting time (known as the International Normalized Ratio or INR) with a new test of blood clot strength, based upon thrombelastography (TEG), researchers at the University of Colorado's Department of Surgery, Denver, are able to quickly and efficiently assess the overall ability of blood to clot and identify trauma patients who were most in need of a massive blood transfusion.
W. Ian Lipkin, director of the Center for Infection and Immunity and John Snow Professor of Epidemiology at the Mailman School of Public Health, has received an award of up to $31 million over a five-year period by the National Institutes of Health (NIH) to establish the Center for Research in Diagnostics and Discovery (CRDD) under the auspices of a new National Institute of Allergy and Infectious Diseases (NIAID) program entitled Centers of Excellence for Translational Research.
› Verified 4 days ago
Cara Bufkin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 773 Maroon Peak Cir, Superior, CO 80027 Phone: 303-362-3656 | |
Elizabeth Cundall, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Marshall Rd, Superior, CO 80027 Phone: 303-209-0107 | |
Dr. Kimberly Jordan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1601 Coalton Rd, Superior, CO 80027 Phone: 303-543-1153 | |
Dr. Erinn Marie Mullins, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 191 S Mccaslin Blvd, Superior, CO 80027 Phone: 303-666-7816 | |
Dr. Craig Thomas Skinner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2855 Rock Creek Cir, Unit 312, Superior, CO 80027 Phone: 303-442-2363 | |
Mrs. Renee Nadine Brewster, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Marshall Rd, Superior, CO 80027 Phone: 303-209-0107 | |
Mr. Steven G Johannes, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Marshall Rd, Superior, CO 80027 Phone: 303-209-0107 Fax: 303-209-0107 |